anubhai
Back OfficeBajaj Finserv Healthcare Fund - Direct (G)
Summary
| Fund Name | Bajaj Finserv Mutual Fund |
| Scheme Name | Bajaj Finserv Healthcare Fund - Direct (G) |
| AMC | Bajaj Finserv Mutual Fund |
| Type | Open |
| Category | Equity - Pharma |
| Launch Date | 06-Dec-2024 |
| Fund Manager | Nimesh Chandan |
| Net Assets(Rs. cr) | 300.45 |
NAV Graph
| One Month | Three Month | Six Month | One Year | Three Year | Five Year |
Latest Payouts
| Dividends | Bonus |
|---|
Performance
| 1 Week (%) | 1 Month (%) | 3 Month (%) | 6 Month (%) | 1 Year (%) | 3 Year (%) | 5 Year (%) | Since INC (%) | |
|---|---|---|---|---|---|---|---|---|
| Scheme Return | 2.17 | 8.71 | 7.38 | -1.02 | 5.49 | 0.00 | 0.00 | -0.37 |
| Category Avg | 1.76 | 6.73 | 6.71 | -1.37 | 4.39 | 23.43 | 14.34 | 13.30 |
| Category Best | 2.79 | 10.77 | 10.44 | 4.30 | 12.06 | 27.67 | 17.04 | 27.48 |
| Category Worst | 0.44 | 4.12 | 0.01 | -5.13 | -2.44 | 19.25 | 10.61 | -6.26 |
Asset Allocation
Holdings
| Company Name | % Hold |
|---|---|
| Sun Pharma.Inds. | 9.41 |
| Divi's Lab. | 8.95 |
| Apollo Hospitals | 6.75 |
| Aurobindo Pharma | 6.63 |
| Piramal Pharma | 5.69 |
| Torrent Pharma. | 5.57 |
| Emcure Pharma | 4.35 |
| Max Healthcare | 4.06 |
| Rubicon Research | 3.84 |
| Neuland Labs. | 3.42 |
| Fortis Health. | 3.18 |
| Ipca Labs. | 2.69 |
| Zydus Wellness | 2.46 |
| Navin Fluo.Intl. | 2.05 |
| Sanofi Consumer | 1.98 |
| Glenmark Pharma. | 1.97 |
| Glaxosmi. Pharma | 1.81 |
| Vijaya Diagnost. | 1.77 |
| Shaily Engineer. | 1.72 |
| Laurus Labs | 1.65 |
| Godrej Consumer | 1.64 |
| Lupin | 1.56 |
| Dr Lal Pathlabs | 1.54 |
| Abbott India | 1.50 |
| Medplus Health | 1.44 |
| Biocon | 1.38 |
| ERIS Lifescience | 1.08 |
| Krishna Institu. | 1.03 |
| Medi Assist Ser. | 0.99 |
| Jubilant Pharmo | 0.95 |
| Emami | 0.85 |
| Astrazeneca Phar | 0.84 |
| C C I | 0.02 |
| Net CA & Others | 3.52 |
| Bajaj Finserv Money Market Fund - Direct (G) | 1.71 |
